20250205352. Compositions Methods (Eli Lilly and)
COMPOSITIONS AND METHODS FOR MODULATING NaV1.8
Abstract: the present disclosure is related to oligonucleotides, antibody-sirna conjugates, or pharmaceutical compositions thereof for inhibiting the expression of nav1.8 gene and methods of using such oligonucleotides, antibody-sirna conjugates, or pharmaceutical compositions thereof in reducing/treating pain or diseases/disorders related to nav1.8.
Inventor(s): Jeffrey BOYLES, Arvind BHATTACHARYA, Patricia BROWN-AUGSBURGER, Michael Caramian COCHRAN, Julian DAVIES, Wendy Loza HOBBS, Yu Yan KWAN, Jonatan MATALONGA BORREL, Jeff S. McDERMOTT, Thiago OLIVA DETANICO, Christopher Earle WALL
CPC Classification: A61K47/6807 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250205352
- Patent Applications
- Eli Lilly and Company
- CPC A61K47/6807
- Jeffrey BOYLES of Indianapolis IN US
- Arvind BHATTACHARYA of San Diego CA US
- Patricia BROWN-AUGSBURGER of Indianapolis IN US
- Michael Caramian COCHRAN of San Diego CA US
- Julian DAVIES of San Diego CA US
- Wendy Loza HOBBS of San Diego CA US
- Yu Yan KWAN of San Diego CA US
- Jonatan MATALONGA BORREL of San Diego CA US
- Jeff S. McDERMOTT of Indianapolis IN US
- Thiago OLIVA DETANICO of San Diego CA US
- Christopher Earle WALL of San Diego CA US